Delivery Order SPE2DB22D9239-SPE2DB25FDL81
- Not listed
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $61,902.91 by the Defense Logistics Agency (DLA) on July 11, 2025, for MACI 3cm x 5cm implant sheets. The delivery order, which carries an ultimate completion date of August 1, 2025, was issued without a set-aside designation. This award is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract (IDC) with...
- The Defense Logistics Agency awarded a delivery order valued at $61,902.91 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of MACI 3cm x 5cm implant sheets. The award, issued on July 25, 2025, with an ultimate completion date of August 15, 2025, operates under a firm fixed-price contract type with no set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite...
- The Defense Logistics Agency awarded DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, a delivery order valued at $61,902.91 for MACI 3cm x 5cm implant sheets. The contract, issued on June 26, 2025, with an ultimate completion date of July 18, 2025, operates under a firm fixed-price structure with no set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $61,538.77 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of MACI 3cm x 5cm implant sheets. This firm fixed-price delivery order was awarded on September 10, 2025, with an ultimate completion date of October 1, 2025, and carries no set-aside designation. The contract represents a discrete order issued under DMS Pharmaceutical Group's larger...
- The Defense Logistics Agency awarded a delivery order valued at $61,538.77 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of MACI 3cm x 5cm implant sheets. This firm fixed-price delivery order was awarded on September 10, 2025, with an ultimate completion date of October 1, 2025, and carries no set-aside designation. The award was issued under DMS Pharmaceutical Group's existing Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order valued at $61,902.91 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of MACI 3cm x 5cm implant sheets. This firm fixed-price delivery order was awarded on July 14, 2025, with an ultimate completion date of August 4, 2025, and represents no set-aside designation. The award falls under DMS Pharmaceutical Group's existing single-award Indefinite Delivery...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at approximately $123.8K by the Defense Logistics Agency (DLA) on August 21, 2025. The delivery order calls for the supply of MACI 3cm x 5cm implant sheets, with an ultimate completion date of September 12, 2025. This contract carries no set-aside designation, allowing DMS Pharmaceutical Group to compete on its merits as a small...
- The Defense Logistics Agency awarded a delivery order valued at $61,902.91 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of MACI 3cm x 5cm implant sheets. The contract is a firm fixed-price delivery order with an ultimate completion date of September 8, 2025, and carries no set-aside designation. This award is issued under DMS Pharmaceutical Group's existing Indefinite Delivery Contract with DLA's SPE2DB...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, has been awarded a delivery order valued at $61,902.91 for MACI 3cm x 5cm implant sheets. The award was issued on July 23, 2025, with an ultimate completion date of August 13, 2025, under a firm fixed-price contract with no set-aside designation. The contract is being funded by the Defense Logistics Agency's Medical Supply Chain and will be performed at the contractor's Park...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $53,318.24 contract is for the delivery of MACI 3CM X 5CM implant sheets to support the recurring medical supply needs of military health facilities. This delivery order is part of a larger indefinite delivery contract (IDC) with DMS Pharmaceutical Group, valued at up to $499,999,999,...
- SPE2DB22D9239Indefinite Delivery Contract
- SPE2DB22D9239-SPE2DB25FDL81Delivery Order
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $61,538.77 by the Defense Logistics Agency (DLA) on September 15, 2025. The delivery order, issued without a set-aside designation, calls for the supply of MACI 3cm x 5cm implant sheets, with an ultimate completion date of October 6, 2025. This award falls under DMS Pharmaceutical Group's larger single-award Indefinite Delivery Contract with the DLA under the SPE2DB program, a $499,999,999 vehicle valid through November 2026 that enables the agency to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items and medical supplies supporting Department of Defense healthcare facilities worldwide. The MACI implant sheets represent a specialized medical consumable within DMS Pharmaceutical Group's extensive portfolio of pharmaceutical products supplied to federal agencies, which includes branded and generic prescription drugs, biologics, and specialty medical devices. As a cornerstone supplier in the federal pharmaceutical supply chain, DMS Pharmaceutical Group leverages its woman-owned small business status to compete effectively for DLA contracts, positioning itself as a critical distributor of prescription drugs and pharmacy services to military health facilities across the globe.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $61.5k | 9/15/25 |